Home » Topics » BioWorld Science

BioWorld Science
RSS

HA-344 shows promise for treating cutaneous metastatic melanoma

Sep. 10, 2021

Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections

Sep. 10, 2021

Discovery of novel antibiotic class of tethered macrocyclic peptides

Sep. 10, 2021

New PIKfyve inhibitors identified at AcuraStem

Sep. 10, 2021

Salk Institute, Sanford Burnham Prebys describe new ULK1 inhibitors

Sep. 10, 2021

StemSynergy Therapeutics patents N-myc proto-oncogene protein inhibitors

Sep. 10, 2021

Small-molecule OXS-7417 shows in vivo AML antitumoral effects

Sep. 10, 2021

AFYX Therapeutics presents preclinical data on anti-TNF antibody delivery through adhesive patch

Sep. 10, 2021

PAQ and Insilico Medicine collaborate to develop therapies through autophagy-dependent degradation

Sep. 9, 2021

Gut bacteria accumulate multiple therapeutic drugs

Sep. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...